ZA844286B - Substituted 6-(thien-2-yl)-3(2h)-pyridazinones and processes for their preparation - Google Patents

Substituted 6-(thien-2-yl)-3(2h)-pyridazinones and processes for their preparation

Info

Publication number
ZA844286B
ZA844286B ZA844286A ZA844286A ZA844286B ZA 844286 B ZA844286 B ZA 844286B ZA 844286 A ZA844286 A ZA 844286A ZA 844286 A ZA844286 A ZA 844286A ZA 844286 B ZA844286 B ZA 844286B
Authority
ZA
South Africa
Prior art keywords
pyridazinones
thien
substituted
processes
preparation
Prior art date
Application number
ZA844286A
Other languages
English (en)
Inventor
Gerd Hilboll
Sigurd Leyck
Gerrit Prop
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of ZA844286B publication Critical patent/ZA844286B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA844286A 1983-06-10 1984-06-06 Substituted 6-(thien-2-yl)-3(2h)-pyridazinones and processes for their preparation ZA844286B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833321012 DE3321012A1 (de) 1983-06-10 1983-06-10 Substituierte 4,5-dihydro-6-(thien-2-yl)-3(2h)-pyridazinone und 6-(thien-2-yl)-3(2h)-pyridazinone sowie verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ZA844286B true ZA844286B (en) 1985-01-30

Family

ID=6201162

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA844286A ZA844286B (en) 1983-06-10 1984-06-06 Substituted 6-(thien-2-yl)-3(2h)-pyridazinones and processes for their preparation

Country Status (10)

Country Link
US (1) US4667033A (fr)
EP (1) EP0128502B1 (fr)
JP (1) JPS6041674A (fr)
AT (1) ATE36852T1 (fr)
DE (2) DE3321012A1 (fr)
DK (1) DK284284A (fr)
ES (1) ES533243A0 (fr)
GR (1) GR82025B (fr)
PT (1) PT78715B (fr)
ZA (1) ZA844286B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783463A (en) * 1985-10-23 1988-11-08 Rorer Pharmaceutical Corporation Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure
DE3606105A1 (de) * 1986-02-26 1987-08-27 Nattermann A & Cie Verfahren zur herstellung von imidazolyl-thiophenaldehyden
DE3626865A1 (de) * 1986-08-08 1988-02-11 Boehringer Mannheim Gmbh Neue pyridazinon-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
TW414795B (en) * 1996-07-01 2000-12-11 Yamanouchi Pharma Co Ltd A thiophene derivative and the pharmaceutical composition
DE102005057924A1 (de) * 2005-12-05 2007-06-06 Merck Patent Gmbh Pyridazinonderivate
WO2013097052A1 (fr) 2011-12-30 2013-07-04 Abbott Laboratories Inhibiteurs de bromodomaine
US9364405B2 (en) 2013-03-13 2016-06-14 Avon Products, Inc. Tyrosinase inhibitors
WO2014164200A1 (fr) 2013-03-13 2014-10-09 Avon Products, Inc Inhibiteurs de la tyrosinase
WO2014158943A1 (fr) * 2013-03-13 2014-10-02 Avon Products, Inc Inhibiteurs de tyrosinase
LT3442972T (lt) 2016-04-15 2020-06-10 Abbvie Inc. Bromodomeno inhibitoriai

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1105281A (en) * 1965-03-03 1968-03-06 Seperic Improvements in and relating to new pyridazone derivatives and process for preparing same
CH557819A (de) * 1970-11-12 1975-01-15 Sandoz Ag Verfahren zur herstellung von neuen 2-(2-hydroxyalkyl)4,5-dihydro-pyridazin(2h)-3-onen.
DE2845456A1 (de) * 1978-10-19 1980-08-14 Merck Patent Gmbh 6-arylpyridazin-3-one und verfahren zu ihrer herstellung
DE3130251A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(4-((omega)-(1-imidazolyl)-alkyl)-phenyl)-3-oxo -2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3130252A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(5-((omega)-(1-imidazolyl)-alkyl)-thien-2-yl)-3-oxo-2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
HU190412B (en) * 1981-09-17 1986-09-29 Warner-Lambert Co,Us Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
IE54598B1 (en) * 1981-11-12 1989-12-06 Ici Plc Pharmaceutically-active pyridylvinylpyridazinones
US4521416A (en) * 1983-03-22 1985-06-04 Warner-Lambert Company 4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones and 6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones

Also Published As

Publication number Publication date
EP0128502A1 (fr) 1984-12-19
DK284284A (da) 1984-12-11
EP0128502B1 (fr) 1988-08-31
DE3321012A1 (de) 1984-12-13
ES8506306A1 (es) 1985-07-01
PT78715A (pt) 1985-01-01
PT78715B (en) 1986-07-15
US4667033A (en) 1987-05-19
DE3473758D1 (en) 1988-10-06
ATE36852T1 (de) 1988-09-15
DK284284D0 (da) 1984-06-08
GR82025B (fr) 1984-12-12
ES533243A0 (es) 1985-07-01
JPS6041674A (ja) 1985-03-05

Similar Documents

Publication Publication Date Title
YU45185B (en) Process for making derivatives of 3(2h)-pyridazinone
DK17983D0 (da) Fremgangsmade til fremstilling af 6-substituerede s-triazol(3,4-a)-ftalazin-derivater
DK422583D0 (da) Fremgangsmade til fremstilling af diazobicyclo-(3,3,1)-nonaner
JPS57175723A (en) Stabilization of silicates
PT79134A (en) Process for the preparation of (substituted) phenylaliphatic-isoxazoles useful as antiviral agents
DE3173954D1 (en) Use of adenosin derivatives for the manufacture of psychopharmacons
DE3473758D1 (en) Substituted 6-(thien-2-yl)-3(2h)-pyridazinones and processes for their preparation
IE830607L (en) Imidazolylphenylpyridazinones
GR71628B (fr)
ZA84562B (en) 2-imino-pyrrolidines,process for their preparation,and therapeutic compositions containing same
GR78106B (fr)
FI843354A (fi) Foerfarande foer framstaellning av nya 4-fenyl-4-oxo-2-ensmoersyraderivat.
GR851657B (fr)
JPS57169472A (en) Novel soluble n2 substituted derivative of 2,4-diamino-5-benzylpyrimidine, manufacture and drug containing same
GR82125B (fr)
GR80173B (en) Spiro (benzofuran-azalkanes), method for their preparation and their use as medicaments
GB8316516D0 (en) Derivatives of pyridazinones
US5162542A (en) Substituted pyrazoline derivatives
ZA831626B (en) New triazine compositions of matter
PT74295B (en) Improved process for the preparation of 7-<(carboxymethoxyimi- no)-1h-pyrazol-3-yl>-amino-3-deacetoxy-3-(1-methyl-1h-tetrazol--5-yl-thio)-cephalosporanic acid
PL243199A1 (en) Process for preparing novel tautomers of trans-4ar-5-n-propylo-4,4a,5,6,7,8,8a,9-octahydro-1h /and 2h/ -pyrazolo/3,4g/quinoline
JPS57153629A (en) Connection of coil for endoscope
DE3370787D1 (en) Process for the preparation of pure silica
ZA851157B (en) The use of cephem compounds as immunomodulators
ZA807209B (en) Derivatives of 2-substituted-6-phenyl-3(2h)-pyridazinone